Align Technology, Inc. Share Price
Equities
ALGN
US0162551016
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 163.51 USD | +0.48% |
|
+2.77% | -21.63% |
| Capitalization | 11.68B 9.92B 9.28B 8.7B 16.05B 1,061B 17.59B 108B 41.81B 499B 43.79B 42.88B 1,808B | P/E ratio 2025 * |
28.6x | P/E ratio 2026 * | 20.6x |
|---|---|---|---|---|---|
| Enterprise value | 10.42B 8.85B 8.28B 7.76B 14.33B 948B 15.7B 96.74B 37.32B 445B 39.09B 38.28B 1,614B | EV / Sales 2025 * |
2.59x | EV / Sales 2026 * | 2.41x |
| Free-Float |
93.4% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Align Technology, Inc.
| 1 day | +0.48% | ||
| 1 week | +2.77% | ||
| Current month | +11.01% | ||
| 1 month | +23.22% | ||
| 3 months | +23.96% | ||
| 6 months | -10.47% | ||
| Current year | -21.63% |
| 1 week | 159.01 |  | 167.02 |
| 1 month | 130.23 | | 167.02 |
| Current year | 122 | | 237.23 |
| 1 year | 122 | | 237.23 |
| 3 years | 122 | | 413.2 |
| 5 years | 122 | | 737.45 |
| 10 years | 57.31 | | 737.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Hogan
CEO | Chief Executive Officer | 67 | 31/05/2015 |
John Morici
DFI | Director of Finance/CFO | 58 | 09/11/2016 |
Srini Kaza
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Larkin
CHM | Chairman | 76 | 29/02/2004 |
Joseph Lacob
BRD | Director/Board Member | 68 | 31/07/1997 |
George Morrow
BRD | Director/Board Member | 73 | 31/01/2006 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.48% | +2.77% | -28.98% | -17.56% | 11.68B | |
| -1.07% | +4.78% | +12.80% | +18.83% | 223B | |
| -0.93% | -2.20% | +19.77% | +26.99% | 126B | |
| -2.35% | +1.19% | +48.51% | +104.64% | 67.96B | |
| -2.08% | +3.65% | -14.00% | -21.56% | 57.11B | |
| -0.29% | +0.31% | +19.23% | +70.27% | 52.41B | |
| -0.08% | -1.13% | -14.17% | -42.79% | 25.64B | |
| -0.58% | -2.00% | +19.48% | +37.75% | 24.94B | |
| +0.48% | +0.10% | +8.69% | -31.46% | 23.72B | |
| +1.18% | -2.22% | -24.06% | +15.07% | 21.76B | |
| Average | -0.52% | +0.77% | +4.73% | +16.02% | 63.5B | |
| Weighted average by Cap. | -0.98% | +2.03% | +13.12% | +25.83% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.03B 3.42B 3.2B 3B 5.54B 366B 6.07B 37.4B 14.43B 172B 15.12B 14.8B 624B | 4.17B 3.54B 3.32B 3.11B 5.74B 379B 6.29B 38.74B 14.94B 178B 15.65B 15.33B 646B |
| Net income | 421M 358M 335M 314M 579M 38.28B 634M 3.91B 1.51B 17.98B 1.58B 1.55B 65.18B | 555M 472M 441M 413M 763M 50.48B 836M 5.15B 1.99B 23.71B 2.08B 2.04B 85.95B |
| Net Debt | -1.25B -1.06B -995M -933M -1.72B -114B -1.89B -11.63B -4.49B -53.5B -4.7B -4.6B -194B | -1.63B -1.38B -1.29B -1.21B -2.24B -148B -2.45B -15.11B -5.83B -69.55B -6.11B -5.98B -252B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/12/25 | 163.48 $ | +0.46% | 471,519 |
| 15/12/25 | 162.73 $ | -1.63% | 1,119,523 |
| 12/12/25 | 165.43 $ | +0.95% | 1,685,911 |
| 11/12/25 | 163.87 $ | -0.43% | 1,188,233 |
| 10/12/25 | 164.58 $ | +3.51% | 1,233,717 |
Delayed Quote Nasdaq, December 16, 2025 at 06:36 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition